出境海岛游、环球邮轮旅游您的无二之旅 - 高端定制旅游专家!今天是:
出国旅行网
旅游网站大全
Current Location: 出国游 > 环球游讯 > TravelNews >

$50billionmarketvalueforhepatitisCmedicaltourismfromChina

Date:2016-10-06Source: Official Site:https://www.jetgo.cn

Overseas medical tourism from Chinese with hepatitis C could potentially be worth more than $50 billion, according to a Founder Securities report.

Chinese people used to travel to the US for cancer treatment and they have snatched up cold medicine and painkillers on trips to Japan. They now go overseas for another medical purpose: curing their liver diseases.

Although treatment of the virus has gone through revolutionary development in the last few years, no direct-acting antiviral agents shown to cure more than 90% of patients within a few months, have yet been approved by Chinese regulator. China still uses old-generation therapies including injections of interferon, which has harsh side effects such as headache and hair loss.

A number of Chinese companies are tapping into the growing population – now estimated at around 10 million – of Chinese infected with hepatitis C with especially designed trips to countries such as India, where Sovaldi and Gilead’s Harvoni are sold at a much cheaper price than the U.S. price tag of $84,000 and $98,000 per regimen, respectively, and to Laos and Bangladesh, where generic versions are available.

A recent report by Founder Securities estimates overseas medical tourism from Chinese with hepatitis C could potentially be worth more than $50 billion. The report doesn’t say how many Chinese have gone abroad in search of a cure.

百度一下:$50billionmarketvalueforhepatitisCmedicaltourismfromChina 查找更多相关信息!


360搜索:$50billionmarketvalueforhepatitisCmedicaltourismfromChina 查找更多相关信息!


Google Search:$50billionmarketvalueforhepatitisCmedicaltourismfromChina Find more information!


欢迎国内外景点、酒店、旅行社合作,免费入驻出国游!E-mail:iyatrip#163.com (请将#号替换为@)


------分隔线----------------------------
说点什么吧
  • 全部评论(0)
    还没有评论,快来抢沙发吧!